Bosutinib
Active substance: bosutinib
TABLET, FILM COATED · BOSUTINIB 500 mg/1
United StatesActive
Marketing holder: Alembic Pharmaceuticals Limited
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- BOSUTINIB · 500 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3ddf-765e-92c1-65eba9d8a1a8,01a1208c-8a1a-7571-8caa-ceb7bfde7374,01a1208c-900f-7e49-99b0-1b5fffd8825b,01a1208f-b7e4-72da-b11a-f5ceda45b1ac,01a1208f-b7e6-7f72-9b38-7423a2d8ca1d;count=11 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 46708-312
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 46708-312 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 46708-312 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 46708-312 · Verified 2026-10-09 · open in source